The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Aprovel

300 milligram(s) Tablet

Sanofi-Aventis GroupeEU/1/97/046/007

Main Information

Trade NameAprovel
Active SubstancesIrbesartan
Strength300 milligram(s)
Dosage FormTablet
Licence HolderSanofi-Aventis Groupe
Licence NumberEU/1/97/046/007

Group Information

ATC CodeC09CA Angiotensin II antagonists, plain
C09CA04 irbesartan

Status

Authorised/WithdrawnAuthorised
Licence Issued
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing Status

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back